Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options

Reducing the dose of Eli Lilly’s obesity shot Zepbound could provide a safe, effective and potentially cheaper option for the maintenance of weight loss, according to new data. The findings come from a trial called ...